课题基金 / 基金详情

Targeting inflammatory and neurodegenerative pathways relevant to progression in the NR1H3 (LXRA) R415Q model of primary progressive multiple sclerosis

Targeting inflammatory and neurodegenerative pathways relevant to progression in the NR1H3 (LXRA) R415Q model of primary progressive multiple sclerosis
靶向与原发性进行性多发性硬化症 NR1H3 (LXRA) R415Q 模型进展相关的炎症和神经退行性通路
批准号：
462072
负责人：
Quandt Jacqueline A
金额：
$66.04万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2027-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=462072&lang=en
关键词：
Demyelination Experimental Autoimmune Encephalomyelitis Multiple Sclerosis Neurodegeneration Neuroinflammation, Neuroprotection Transgenic Mice

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple sclerosis (MS) is the most common cause of neurological disability, other than trauma, in young adults. Approximately 100,000 Canadians, and over two million people worldwide have MS. Canada already has one of the highest rates of MS in the world
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金